Previous 10 | Next 10 |
NEW HAVEN, Conn., Jan. 28, 2020 (GLOBE NEWSWIRE) -- The management team of Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), would like to provide an explanation on the recent Amendment to the S-1 that was filed yesterday, on January 27, 2020. The company filed its S-1...
Home DNA testing services provider 23andMe ( DNA ) plans to terminate 100 people, 14% of its workforce, in response to weakening sales. Most of the cuts will affect operations teams that were focused on growth and scaling efforts. More news on: 23andMe, Anixa Biosciences, Inc., Guardant ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
NEW HAVEN, Conn., Jan. 15, 2020 (GLOBE NEWSWIRE) -- The management team of Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), would like to provide several clarification points related to the recent S-1 that was filed yesterday, on January 14, 2020: Yesterday’s ...
NEW HAVEN, Conn., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that on Monday, January 20th at 5pm it will conduct a shareholder update call with regard to several strategic initiatives for 2020 as well as the current statu...
Everyone Wants To Know If You Can Make Money With Penny Stocks Investing in penny stocks can often be one of the most rewarding activities if you find winning trades. Over the years, plenty of investors have managed to make fortunes through sound investments in cheap stocks. Critics will arg...
Gainers: Kaixin Auto (NASDAQ: KXIN ) +32% . More news on: Kaixin Auto Holdings, NantKwest, Inc., Renewable Energy Group, Inc., Stocks on the move, Read more ...
Largest healthcare provider in New York becomes the first IV-Cell customer NEW HAVEN, CT / ACCESSWIRE / December 17, 2019 / Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), today announced the receipt of their first commercial order for IV-Cell from Northwell Heal...
Douglas Fisher, MD will assume the role of interim Chairman of the Board NEW HAVEN, CT / ACCESSWIRE / December 4, 2019 / Specialty diagnostics company Precipio, Inc. ( NASDAQ:PRPO ), announced the resignation of Samuel Riccitelli from the board of directors, and his replacement by Ric...
Testing and revenues will begin in Q4 and continue into Q1-2020 NEW HAVEN, CT / ACCESSWIRE / November 14, 2019 / Specialty diagnostics company Precipio, Inc. ( NASDAQ:PRPO ), announced a substantial biomarker project with a large healthcare company that will generate significant reven...
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. Patholog...
NEW HAVEN, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , today announced that the company’s 2024 Annual Meeting of Shareholders (“Annual Meeting”) was convened and adjourned, without any business being conducted...
NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately today no later than 11pm Eastern Time. In order to e...